Projected impact of a plant-derived vaccine on the burden of seasonal influenza in Canada.
Lauren RamjeeWilliam LemayNesrin VurgunNathalie CharlandChris T BauchGokul Raj PullaguraSherilyn K D HouleGabriel TremblayPublished in: Human vaccines & immunotherapeutics (2021)
Use of plant-derived QVLP influenza vaccines may contribute to greater reductions in influenza cases and influenza-related outcomes, including inpatient admissions and deaths, compared to egg-derived vaccines currently available in Canada.